학술논문

Absence of microglia promotes diverse pathologies and early lethality in Alzheimer’s disease mice
Document Type
article
Source
Cell Reports. 39(11)
Subject
Biochemistry and Cell Biology
Biological Sciences
Dementia
Neurosciences
Alzheimer's Disease
Aging
Vascular Cognitive Impairment/Dementia
Acquired Cognitive Impairment
Genetics
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Cerebrovascular
Neurodegenerative
Prevention
Alzheimer's Disease Related Dementias (ADRD)
Brain Disorders
2.1 Biological and endogenous factors
Aetiology
Neurological
Alzheimer Disease
Amyloid beta-Peptides
Animals
Brain
Cerebral Amyloid Angiopathy
Disease Models
Animal
Humans
Induced Pluripotent Stem Cells
Membrane Glycoproteins
Mice
Mice
Transgenic
Microglia
Plaque
Amyloid
Receptors
Immunologic
Alzheimer’s disease
Alzheimer’s disease co-pathologies
CP: Neuroscience
TREM2
brain calcification
cerebral amyloid angiopathy
hemorrhage
iPSC-microglia
microglia
mortality
neurovascular
Medical Physiology
Biological sciences
Language
Abstract
Microglia are strongly implicated in the development and progression of Alzheimer's disease (AD), yet their impact on pathology and lifespan remains unclear. Here we utilize a CSF1R hypomorphic mouse to generate a model of AD that genetically lacks microglia. The resulting microglial-deficient mice exhibit a profound shift from parenchymal amyloid plaques to cerebral amyloid angiopathy (CAA), which is accompanied by numerous transcriptional changes, greatly increased brain calcification and hemorrhages, and premature lethality. Remarkably, a single injection of wild-type microglia into adult mice repopulates the microglial niche and prevents each of these pathological changes. Taken together, these results indicate the protective functions of microglia in reducing CAA, blood-brain barrier dysfunction, and brain calcification. To further understand the clinical implications of these findings, human AD tissue and iPSC-microglia were examined, providing evidence that microglia phagocytose calcium crystals, and this process is impaired by loss of the AD risk gene, TREM2.